{"entity":{"type":"insider","cik":"0001699848","url":"/insider/0001699848","json_url":"/insider/0001699848.json","name":"Valle Franco","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":9,"first":"2020-03-04","last":"2024-06-12","span_basis":"filed_date"},"name_variants":[{"name":"Valle Franco","source":"filing","n_filings":9,"first_seen":"2020-03-04","last_seen":"2024-06-12"}],"transactions":[{"id":2343820,"accession":"0000950170-24-072494","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-072494","line_url":"/filing/0000950170-24-072494#line-2","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12509.0,"shares_display":"12,509","price_per_share":4.4257,"price_display":"4.43","price_state":"stated","total_value":55361.0813,"total_display":"55,361.08","total_whole":"55,361","shares_owned_after":42500.0,"shares_owned_after_display":"42,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-06-11","filed_date":"2024-06-12","scope":"insider"},{"id":6620811,"accession":"0000899243-22-035697","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035697","line_url":"/filing/0000899243-22-035697#line-1","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4100.0,"shares_display":"4,100","price_per_share":7.6307,"price_display":"7.63","price_state":"stated","total_value":31285.87,"total_display":"31,285.87","total_whole":"31,286","shares_owned_after":17407.0,"shares_owned_after_display":"17,407","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-11","filed_date":"2022-11-14","scope":"insider"},{"id":6669696,"accession":"0000899243-22-002217","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-002217","line_url":"/filing/0000899243-22-002217#line-1","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Biomea Fusion, Inc.","issuer_ticker":"BMEA","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":8.6767,"price_display":"8.68","price_state":"stated","total_value":86767.0,"total_display":"86,767.00","total_whole":"86,767","shares_owned_after":10000.0,"shares_owned_after_display":"10,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-14","filed_date":"2022-01-18","scope":"insider"},{"id":5087479,"accession":"0000899243-21-001847","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-21-001847","line_url":"/filing/0000899243-21-001847#line-4","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1747.0,"shares_display":"1,747","price_per_share":125.445,"price_display":"125.44","price_state":"stated","total_value":219152.415,"total_display":"219,152.42","total_whole":"219,152","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-12","filed_date":"2021-01-13","scope":"insider"},{"id":5087477,"accession":"0000899243-21-001847","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-001847","line_url":"/filing/0000899243-21-001847#line-2","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":125.605,"price_display":"125.60","price_state":"stated","total_value":188407.5,"total_display":"188,407.50","total_whole":"188,408","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-01-11","filed_date":"2021-01-13","scope":"insider"},{"id":2385407,"accession":"0000899243-20-030728","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030728","line_url":"/filing/0000899243-20-030728#line-2","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1623.0,"shares_display":"1,623","price_per_share":74.9287,"price_display":"74.93","price_state":"stated","total_value":121609.2801,"total_display":"121,609.28","total_whole":"121,609","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-09","filed_date":"2020-11-10","scope":"insider"},{"id":2513485,"accession":"0000899243-20-027918","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-20-027918","line_url":"/filing/0000899243-20-027918#line-4","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5199.0,"shares_display":"5,199","price_per_share":74.8511,"price_display":"74.85","price_state":"stated","total_value":389150.8689,"total_display":"389,150.87","total_whole":"389,151","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-08","filed_date":"2020-10-09","scope":"insider"},{"id":2513475,"accession":"0000899243-20-027918","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-027918","line_url":"/filing/0000899243-20-027918#line-2","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5444.0,"shares_display":"5,444","price_per_share":75.0823,"price_display":"75.08","price_state":"stated","total_value":408748.0412,"total_display":"408,748.04","total_whole":"408,748","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-07","filed_date":"2020-10-09","scope":"insider"},{"id":2132626,"accession":"0000899243-20-011154","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-011154","line_url":"/filing/0000899243-20-011154#line-2","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":49.79,"price_display":"49.79","price_state":"stated","total_value":99580.0,"total_display":"99,580.00","total_whole":"99,580","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-20","filed_date":"2020-04-22","scope":"insider"},{"id":3111118,"accession":"0000899243-20-009640","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-009640","line_url":"/filing/0000899243-20-009640","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":48.262,"price_display":"48.26","price_state":"stated","total_value":241310.0,"total_display":"241,310.00","total_whole":"241,310","shares_owned_after":2000.0,"shares_owned_after_display":"2,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-26","filed_date":"2020-03-30","scope":"insider","n_lines":2},{"id":2418096,"accession":"0000899243-20-006944","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-20-006944","line_url":"/filing/0000899243-20-006944","is_derivative":false,"issuer_cik":"0001699848","issuer_name":"Eidos Therapeutics, Inc.","issuer_ticker":"EIDX","issuer_name_source":null,"issuer_url":"/issuer/0001699848","owner_cik":"0001699848","owner_name":"Valle Franco","owner_display_name":"Valle Franco","owner_url":"/insider/0001699848","role":"Officer (Senior Vice President, Finance)","role_mark":"O","role_mark_label":"Officer (Senior Vice President, Finance)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Senior Vice President, Finance","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3000.0,"shares_display":"3,000","price_per_share":52.32666666666667,"price_display":"52.33","price_state":"stated","total_value":156980.0,"total_display":"156,980.00","total_whole":"156,980","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-02","filed_date":"2020-03-04","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001840439","name":"Biomea Fusion, Inc.","url":"/issuer/0001840439","role":"Officer (Chief Financial Officer)","n_filings":3,"first_seen":"2022-01-18","last_seen":"2024-06-12"},{"type":"issuer","type_label":"ISSUER","cik":"0001731831","name":"Eidos Therapeutics, Inc.","url":"/issuer/0001731831","role":"Officer (Senior Vice President, Finance)","n_filings":6,"first_seen":"2020-03-04","last_seen":"2021-01-13"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001699848","retrieved_at":"2026-08-23T15:43:45+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}